查詢結果分析
相關文獻
- 進展性非小細胞肺癌之病例用藥探討
- Newly Developing Osteoblastic Lesions during Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Do Not Necessarily Indicate Disease Progression
- Primary Resistance to Gefitinib in a Patient with Lung Adenocarcinoma Presenting as a Rare Form of Umbilical Metastasis
- 抗血管新生治療於非小細胞肺癌之應用
- Outcomes of Mechanically Ventilated Non-Small Cell Lung Cancer Patients Receiving Tyrosine Kinase Inhibitors in Intensive Care Units
- EGFR-TKIs用於晚期非小細胞肺癌
- 治療晚期非小細胞肺癌的表皮生長因子受體-酪胺酸激酶抑制劑
- 非小細胞肺癌的標靶治療
- 非小細胞肺癌第三代EGFR酪胺酸激酶抑制劑Osimertinib
- 非小細胞肺癌術前輔助性化學治療的經驗
頁籤選單縮合
題名 | 進展性非小細胞肺癌之病例用藥探討= |
---|---|
作者 | 盧志嘉; 蔡涵怡; 周月卿; |
期刊 | 醫院藥學 |
出版日期 | 20100300 |
卷期 | 27:1/2 2010.03[民99.03] |
頁次 | 頁48-56 |
分類號 | 418.31 |
語文 | chi |
關鍵詞 | 非小細胞肺癌; 雙效療法; 表皮生長因子接受體; 酪胺酸激酶抑制劑; 嗜中性白血球低下併發燒; Non-small cell lung cancer; NSCLC; Doublet; Epidermal growth factor receptor; EGFR; Tyrosine kinase inhibitor; TKI; Febrile neutropenia; |